Alignment Healthcare, Inc. Common Stock (ALHC) Stock
Key stats
- Market cap
- $1.61B
- Price / Earnings ratio
- 55.5x
- EPS (TTM)
- $0.15
- Volume
- Loading
- 52-week high
- $25.12
- 52-week low
- $6.01
Source: third-party data provider, as of November 13, 2026
Compare with ALHC
Recent news

ALHC Legal Notice: Alignment Healthcare Investors are Notified to Contact BFA Law About the Ongoing Securities Fraud Investigation
ALHC Legal Notice: Alignment Healthcare Investors are Notified to Contact BFA Law About the Ongoing Securities Fraud Investigation
ALHC

What Alignment Healthcare (ALHC) Said on Its Q3 Earnings Call
What Alignment Healthcare (ALHC) Said on Its Q3 Earnings Call
ALHC

Alignment Healthcare (ALHC) Reports Q3 Loss, Beats Revenue Estimates
Alignment Healthcare (ALHC) Reports Q3 Loss, Beats Revenue Estimates
ALHC

Here's What Key Metrics Tell Us About Alignment Healthcare (ALHC) Q3 Earnings
Here's What Key Metrics Tell Us About Alignment Healthcare (ALHC) Q3 Earnings
ALHC
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 44.41
- MACD 12/26/9
- -0.41
- EMA 9 of MACD
- -0.48
- MACD histogram
- 0.08
- SMA 50
- $8.91
- Price below SMA 50
- EMA 50
- $9.32
- Price below EMA 50
- SMA 200
- $16.19
- Price below SMA 200
- EMA 200
- $14.88
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 7 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

ALHC Legal Notice: Alignment Healthcare Investors are Notified to Contact BFA Law About the Ongoing Securities Fraud Investigation
ALHC Legal Notice: Alignment Healthcare Investors are Notified to Contact BFA Law About the Ongoing Securities Fraud Investigation
ALHC

What Alignment Healthcare (ALHC) Said on Its Q3 Earnings Call
What Alignment Healthcare (ALHC) Said on Its Q3 Earnings Call
ALHC

Alignment Healthcare (ALHC) Reports Q3 Loss, Beats Revenue Estimates
Alignment Healthcare (ALHC) Reports Q3 Loss, Beats Revenue Estimates
ALHC

Here's What Key Metrics Tell Us About Alignment Healthcare (ALHC) Q3 Earnings
Here's What Key Metrics Tell Us About Alignment Healthcare (ALHC) Q3 Earnings
ALHC

Analysts Estimate Alignment Healthcare (ALHC) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Alignment Healthcare (ALHC) to Report a Decline in Earnings: What to Look Out for
ALHC

ALHC Stock Drop Alert: BFA Law Announces Securities Fraud Investigation Into Alignment Healthcare Following Alleged Adjusted EBITDA Manipulation
ALHC Stock Drop Alert: BFA Law Announces Securities Fraud Investigation Into Alignment Healthcare Following Alleged Adjusted EBITDA Manipulation
ALHC

Alignment Healthcare Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Alignment Healthcare, Inc. - ALHC
Alignment Healthcare Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Alignment Healthcare, Inc. - ALHC
ALHC

CVS vs. ALHC: Which Medicare Advantage Stock Is the Better Pick Now?
CVS vs. ALHC: Which Medicare Advantage Stock Is the Better Pick Now?
ALHC

HUM Stock Soars, ALHC Sinks As CMS Star Ratings Redraw 2028 Bonuses
HUM Stock Soars, ALHC Sinks As CMS Star Ratings Redraw 2028 Bonuses
ALHC

Rosen Law Firm Encourages Alignment Healthcare, Inc. Investors to Inquire About Securities Class Action Investigation - ALHC
Rosen Law Firm Encourages Alignment Healthcare, Inc. Investors to Inquire About Securities Class Action Investigation - ALHC
ALHC
News tone: automated (AI) classification of the article's content, not a price prediction.
About Alignment Healthcare, Inc. Common Stock
No description available.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. John E. Kao | Founder, Chairman & CEO | 1962 |
| Mr. James M. Head | Chief Financial Officer | 1966 |
| Mr. Joseph Samuel Konowiecki J.D. | Vice Chairman & Executive VP of Corporate Affairs | 1954 |
| Ms. Dawn Christine Maroney | President | 1968 |
| Mr. Christopher J. Joyce J.D. | Chief Legal & Administrative Officer | 1964 |
| Dr. Hyong J. Kim M.D. | Chief Medical Officer | 1970 |
| Dr. Donald S. Furman M.B.A., M.D. | Co-Founder & Chief Clinical Officer | 1951 |
| Shane Hochradel | Chief Operations Officer | — |
| Mr. Robert L. Scavo | Chief Information Officer | 1965 |
| Mr. Andreas Wagner | Chief Human Resources Officer | 1970 |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 44.41
- MACD 12/26/9
- -0.41
- EMA 9 of MACD
- -0.48
- MACD histogram
- 0.08
- SMA 50
- $8.91
- Price below SMA 50
- EMA 50
- $9.32
- Price below EMA 50
- SMA 200
- $16.19
- Price below SMA 200
- EMA 200
- $14.88
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
7 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $8.00
- Average
- $8.75
- High
- $10.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -27.9 | -7.3 | ||||||||||
| 2022 | -45.5 | +9.6 | +33.1 | -18.0 | +6.6 | +11.5 | +26.4 | +3.3 | -20.0 | +8.5 | -2.8 | -9.6 |
| 2023 | +6.4 | -20.4 | -20.8 | -7.1 | -14.3 | -2.5 | +7.3 | -0.7 | +20.7 | -2.1 | +12.6 | +17.0 |
| 2024 | -21.1 | -7.4 | -12.1 | +4.5 | +51.0 | -2.1 | +9.7 | +4.5 | +20.5 | +24.0 | -2.6 | -12.4 |
| 2025 | +33.1 | +2.1 | +20.0 | -2.0 | -8.3 | -9.7 | -3.0 | +26.1 | +4.9 | +0.2 | +14.1 | +3.5 |
| 2026 | +11.4 | -15.1 | -10.3 | +26.3 | -24.4 | +79.0 | -38.2 | -8.0 | -40.0 | -6.1 | +9.9 |



